Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Gynecol Obstet Fertil Senol ; 49(9): 698-702, 2021 Sep.
Article in French | MEDLINE | ID: mdl-33933672

ABSTRACT

Breast damage is likely to result in compensation according to the principle of full compensation. However, breast damage, little covered in the scales usually used, requires a specific methodology. The quantification of functional prejudice must be done with regard to the age of the victim and must take into account the possible repercussions on mobility (shoulder and/or spine) as well as the psychological repercussions. Whether or not the nipple and areola are preserved should be described. Temporary aesthetic damage (before breast reconstruction) must be assessed on the basis of objective elements, its duration and quantification on a scale of 0 to 7. Permanent aesthetic damage takes into account scars, deformities, amputations and quality of the prosthesis. A new scale for evaluating permanent aesthetic damage is proposed. Sexual prejudice must take into account an impairment of the pleasure related to sexuality and its erotic function, in line with the concept of sexual health. However, even after reconstruction, the areas of quality of sexual life and sexual satisfaction often remain affected. An exploration using standardized questions from validated questionnaires such as BREAST-Q can be useful. The sequelae linked to the damage on a breast can also lead the woman to limit certain pleasure activities, in particular because of psychological discomfort or even be the cause of a loss of opportunity to carry out a family's life plan.


Subject(s)
Breast Neoplasms , Mammaplasty , Breast Neoplasms/surgery , Esthetics , Female , Humans , Nipples/surgery , Patient Satisfaction , Surveys and Questionnaires
2.
Allergy ; 71(4): 550-5, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26606505

ABSTRACT

BACKGROUND: Argan is used worldwide in numerous cosmetic products, as this fruit is supposed to have many beneficial properties on health. New cases of allergy can be expected with the growing use of argan. We investigated all workers (9) employed by a cosmetic factory and exposed to argan powder to identify possible allergies related to exposure to argan powder. METHODS: Patients were investigated in the occupational disease department and, according to their symptoms, underwent pulmonary function testing, methacholine challenge, specific inhalation challenge to argan powder, skin prick tests, and immunoblotting analysis. RESULTS: We report three cases of occupational asthma to argan powder and a probable case of rhinitis. Fifteen argan proteins were recognized by the patients' IgE. Identification of proteins, cross-reactions to nuts, and ELISA inhibition tests suggested that some argan allergens can cross-react in vitro with hazelnut allergens, including 11S globulin and vicilin. CONCLUSION: High-level exposure to argan powder should be considered to be a potential cause of IgE-mediated allergy, and workers handling argan powder should be carefully investigated.


Subject(s)
Allergens/immunology , Antigens, Plant/immunology , Asthma, Occupational/epidemiology , Asthma, Occupational/etiology , Cosmetics/adverse effects , Occupational Exposure/adverse effects , Sapotaceae/adverse effects , Adult , Asthma, Occupational/diagnosis , Bronchial Provocation Tests , Female , Humans , Immunoglobulin E/blood , Immunoglobulin E/immunology , Male , Middle Aged , Risk Factors , Skin Tests
3.
Eur J Surg Oncol ; 41(10): 1361-7, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26263848

ABSTRACT

BACKGROUND: Over the last two decades, many surgical teams have developed programs to treat peritoneal carcinomatosis with extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Currently, there are no specific recommendations for HIPEC procedures concerning environmental contamination risk management, personal protective equipment (PPE), or occupational health supervision. METHODS: A survey of the institutional practices among all French teams currently performing HIPEC procedures was carried out via the French network for the treatment of rare peritoneal malignancies (RENAPE). RESULTS: Thirty three surgical teams responded, 14 (42.4%) which reported more than 10 years of HIPEC experience. Some practices were widespread, such as using HIPEC machine approved by the European Community (100%), individualized or centralized smoke evacuation (81.8%), "open" abdominal coverage during perfusion (75.8%), and maintaining the same surgeon throughout the procedure (69.7%). Others were more heterogeneous, including laminar flow air circulation (54.5%) and the provision of safety protocols in the event of perfusate spills (51.5%). The use of specialized personal protective equipment is ubiquitous (93.9%) but widely variable between programs. CONCLUSION: Protocols regarding cytoreductive surgery/HIPEC and the associated professional risks in France lack standardization and should be established.


Subject(s)
Air Conditioning/methods , Antineoplastic Agents/therapeutic use , Carcinoma/therapy , Cytoreduction Surgical Procedures/methods , Hyperthermia, Induced/methods , Infusions, Parenteral/methods , Peritoneal Neoplasms/therapy , Personal Protective Equipment/statistics & numerical data , Practice Patterns, Physicians' , France , Humans , Occupational Health , Risk Management , Smoke , Surveys and Questionnaires
4.
Int J Tuberc Lung Dis ; 16(1): 138-9, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22236860

ABSTRACT

The present case study reports the first case of a 38-year-old hairdresser with irritant-associated vocal cord dysfunction (VCD) due to alkaline persulfate, who was referred on suspicion of occupational asthma. Several tests were performed, including specific inhalation challenge and upper airway endoscopy. During the specific inhalation challenge to alkaline persulfate, the patient experienced dysphonia and a non-significant decrease in forced expiratory volume in 1 second on spirometry. Upper airway endoscopy was then performed and revealed VCD. A specific inhalation challenge test is therefore essential in cases of VCD to exclude possible concomitant occupational asthma.


Subject(s)
Beauty Culture , Dysphonia/chemically induced , Hair Bleaching Agents/adverse effects , Irritants/adverse effects , Occupational Diseases/chemically induced , Vocal Cords/drug effects , Adult , Asthma/diagnosis , Bronchial Provocation Tests , Diagnosis, Differential , Dysphonia/diagnosis , Dysphonia/physiopathology , Endoscopy , Female , Forced Expiratory Volume , Humans , Inhalation Exposure , Occupational Diseases/diagnosis , Occupational Diseases/physiopathology , Occupational Exposure , Predictive Value of Tests , Spirometry , Vocal Cords/physiopathology
5.
Bull Cancer ; 96(10): 971-7, 2009 Oct.
Article in French | MEDLINE | ID: mdl-19762323

ABSTRACT

To develop a treatment strategy for peritoneal carcinomatosis using a combination of extended peritoneal resections, local destructive procedures and hyperthermic intraperitoneal chemotherapy creates great concern between healthcare workers involved in these procedures. New professional risks exist: risk of exposure to cytotoxic drugs, environmental risks (inhalation of smoke, aerosolization of chemotherapy agents). Information, education and training of healthcare workers is mandatory in order to ensure proper evaluation, prevention, and management of professional exposure risks in coordination with the occupational health office.


Subject(s)
Antineoplastic Agents/adverse effects , Carcinoma/drug therapy , Chemotherapy, Cancer, Regional Perfusion/adverse effects , Hot Temperature , Occupational Exposure/prevention & control , Peritoneal Neoplasms/drug therapy , Air Pollutants, Occupational/toxicity , Antineoplastic Agents/administration & dosage , Camptothecin/administration & dosage , Camptothecin/adverse effects , Camptothecin/analogs & derivatives , Carcinoma/surgery , Chemotherapy, Cancer, Regional Perfusion/education , Chemotherapy, Cancer, Regional Perfusion/methods , Cisplatin/administration & dosage , Cisplatin/adverse effects , Decontamination/methods , Doxorubicin/administration & dosage , Doxorubicin/adverse effects , Drug Compounding/adverse effects , Electrosurgery/adverse effects , Humans , Irinotecan , Mitomycin/administration & dosage , Mitomycin/adverse effects , Occupational Exposure/adverse effects , Operating Rooms , Organoplatinum Compounds/administration & dosage , Organoplatinum Compounds/adverse effects , Peritoneal Neoplasms/surgery , Protective Clothing , Pyridines/administration & dosage , Pyridines/adverse effects , Smoke/adverse effects , Ventilation/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...